Cochrane review of Stem cell transplantation in systemic sclerosis (3RCTs w/ 125 pts). Nonâmyeloablative & myeloab
Tweet Content
Cochrane review of Stem cell transplantation in systemic sclerosis (3RCTs w/ 125 pts). Non‐myeloablative & myeloablative selective HSCT had moderate evidence for improved survival, skin thickness & function. But these had high Serious AE rates. https://t.co/qUOfMVSxGZ https://t.co/4icaRdC2EI
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off